Press Releases - 2022-06-08

Date	Title	Company
08-Jun-2022	RNA Analysis/Transcriptomics Global Market Research Report 2022: Microarrays, Sequencing, PCR, RNA Interference, Clinical Diagnostics, Drug Discovery, Toxicogenomics, Comparative Transcriptomics - ResearchAndMarkets.com	Businesswire
08-Jun-2022	KalVista Pharmaceuticals Presents Promising Preclinical Data for Oral Factor XIIa Inhibitor Program	Businesswire
08-Jun-2022	Merck to Participate in the 2022 Goldman Sachs 43rd Annual Global Healthcare Conference	Businesswire
08-Jun-2022	Skipasund Foundation donates vital PPE to frontline workers in Ukraine	Skipasund Foundation
08-Jun-2022	Alvotech et Oaktree Acquisition Corp. II annoncent l'approbation des actionnaires pour le regroupement d'entreprises	Businesswire
08-Jun-2022	First patient dosed in second Phase 2 add-on Ketamine Trial in Treatment-Resistant Depression (TRD)	HMNC Brain Health
08-Jun-2022	Cellbox Solutions Releases Its New Product Generation - Cellbox 2.0 - Innovative Portable Incubator Now with Longer Runtime, CFR21/11 Clinical Trial Compatibility and More	Cellbox Solutions
08-Jun-2022	Tiziana Life Sciences Announces Positive Clinical Results in the Second Patient with Secondary Progressive Multiple Sclerosis (SPMS) Following Three Months of Dosing with Intranasal Foralumab	Tiziana Life Sciences
08-Jun-2022	Atom Bioscience to Update Clinical Development of New Drug to Treat Gout at BIO International Convention, June 13 – 16, 2022, San Diego, CA	Businesswire
08-Jun-2022	Gerresheimer AG: Annual General Meeting of Gerresheimer AG approves dividend of EUR 1.25 per share following a successful financial year – Gradual renewal of Supervisory Board initiated	Gerresheimer AG
08-Jun-2022	Cellbox Solutions Releases Its New Product Generation - Cellbox 2.0 - Innovative Portable Incubator Now with Longer Runtime, CFR21/11 Clinical Trial Compatibility and More	B3C newswire
08-Jun-2022	RWS Announces Appointment of General Managers to Language and Content Technology Division	Businesswire
08-Jun-2022	Malaria breakthrough. A collaboration between ISS, IRBM and CNR has led to the discovery of new molecules blocking the transmission of the parasite.	Istituto Superiore di Sanità
08-Jun-2022	Parse Biosciences Announces Partnership with Molecular Diagnostics Korea	Parse Biosciences
08-Jun-2022	FDA approves Dupixent® (dupilumab) as first biologic medicine for children aged 6 months to 5 years with moderate-to-severe atopic dermatitis	Sanofi
08-Jun-2022	Future Digital Award Winners Announced for Digital Health Innovation 2022	Juniper Research
08-Jun-2022	ImaginAb and Roche have entered a clinical trial supply agreement for provision of atezolizumab (Tecentriq®)1 to Non-Small Cell Lung Cancer Patients Enrolled in ImaginAb’s iPREDICT Phase IIb Study	ImaginAb Inc.
08-Jun-2022	Ariceum Therapeutics Launches with EUR 25M Series A to Advance Lead Asset, Satoreotide, for the Treatment of Low- and High-Grade Neuroendocrine Cancers	Ariceum Therapeutics
08-Jun-2022	University of Manchester Adds Carterra’s LSA® Instrument for High-Throughput Antibody Screening and Characterization	University of Manchester
08-Jun-2022	Synklino completes Series A raise of EUR 29.8 million to advance clinical trials of its drug candidate for the treatment of Cytomegalovirus (CMV)	Synklino